1. Home
  2. EML vs VRCA Comparison

EML vs VRCA Comparison

Compare EML & VRCA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Eastern Company (The)

EML

Eastern Company (The)

HOLD

Current Price

$21.87

Market Cap

133.9M

ML Signal

HOLD

Logo Verrica Pharmaceuticals Inc.

VRCA

Verrica Pharmaceuticals Inc.

HOLD

Current Price

$6.19

Market Cap

137.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EML
VRCA
Founded
1858
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
133.9M
137.3M
IPO Year
1995
2018

Fundamental Metrics

Financial Performance
Metric
EML
VRCA
Price
$21.87
$6.19
Analyst Decision
Buy
Analyst Count
0
2
Target Price
N/A
$17.00
AVG Volume (30 Days)
16.0K
47.3K
Earning Date
05-12-2026
05-11-2026
Dividend Yield
1.98%
N/A
EPS Growth
185.40
N/A
EPS
0.11
N/A
Revenue
$248,970,345.00
$35,577,000.00
Revenue This Year
$19.05
N/A
Revenue Next Year
N/A
$94.44
P/E Ratio
$199.09
N/A
Revenue Growth
N/A
370.22
52 Week Low
$17.61
$0.52
52 Week High
$26.76
$9.82

Technical Indicators

Market Signals
Indicator
EML
VRCA
Relative Strength Index (RSI) 60.97 50.43
Support Level $21.54 $6.15
Resistance Level $22.80 $6.40
Average True Range (ATR) 0.48 0.49
MACD 0.09 0.00
Stochastic Oscillator 87.81 57.58

Price Performance

Historical Comparison
EML
VRCA

About EML Eastern Company (The)

The Eastern Co manages industrial businesses that design, manufacture, and sell engineered solutions to the industrial market. The company manages the financial, operational, and strategic performance of its businesses to increase cash generation, operating earnings, and long-term shareholder value. It has one reportable segment: Engineered Solutions, which provides engineered solutions mainly for the commercial transportation and logistics markets. This segment offers a diverse product line of custom and standard vehicular and industrial hardware, including turnkey returnable packaging solutions, blow molds, compression latches, draw latches, hinges, camlocksaccess, mirrors, and mirror-cameras, among other products. Geographically, the group derives maximum revenue from the United States.

About VRCA Verrica Pharmaceuticals Inc.

Verrica Pharmaceuticals Inc is a therapeutics company developing and commercializing medications for the treatment of dermatologic diseases, including skin cancers. Its commercial product and portfolio of product candidates are clinician administered therapies in areas of high unmet need. This product portfolio consists of one product with an approved indication for molluscum contagiosum, or molluscum, with the potential for several follow-on indications, as well as additional pipeline product candidates. Its commercial product, YCANTH (VP-102), for the treatment of molluscum in adult and pediatric patients two years of age and older. YCANTH (VP-102) is a proprietary drug-device combination that contains a GMP-controlled formulation of cantharidin.

Share on Social Networks: